These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12067805)

  • 1. Telomerase inhibition and the future management of head-and-neck cancer.
    McCaul JA; Gordon KE; Clark LJ; Parkinson EK
    Lancet Oncol; 2002 May; 3(5):280-8. PubMed ID: 12067805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeres and telomerase as targets for cancer therapy.
    Zimmermann S; Martens UM
    Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibitors for the treatment of cancer: the current perspective.
    Perry PJ; Arnold JR; Jenkins TC
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibitors as anticancer therapy.
    Akiyama M; Hideshima T; Munshi NC; Anderson KC
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells.
    McCaul JA; Gordon KE; Minty F; Fleming J; Parkinson EK
    Oral Oncol; 2008 Mar; 44(3):261-9. PubMed ID: 17475542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
    Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
    Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeres, telomerase, and apoptosis.
    Mondello C; Scovassi AI
    Biochem Cell Biol; 2004 Aug; 82(4):498-507. PubMed ID: 15284903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Telomerase activity of tumors in the head and neck].
    Kagata HY; Tsukuda M; Mochimatsu I; Kubota A; Furukawa MK; Yasumoto S
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Feb; 101(2):205-11. PubMed ID: 9545766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
    Chen W; Chen SM; Yu Y; Xiao BK; Huang ZW; Tao ZZ
    J Laryngol Otol; 2010 Jul; 124(7):778-83. PubMed ID: 20403221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase and its potential for therapeutic intervention.
    Phatak P; Burger AM
    Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
    Jafri MA; Ansari SA; Alqahtani MH; Shay JW
    Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere inhibition and telomere disruption as processes for drug targeting.
    Rezler EM; Bearss DJ; Hurley LH
    Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase: biology and phase I trials.
    Kelland LR
    Lancet Oncol; 2001 Feb; 2(2):95-102. PubMed ID: 11905801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres: hallmarks of radiosensitivity.
    Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
    Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomeres, telomerase and cancer].
    Soria JC; Rixe O
    Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.